Education
About Us
Working with TipRanks
Follow Us
Oscar Health (OSCR)
NYSE:OSCR
OSCR Stock Chart & Stats
$13.60
$0.74(5.14%)
At close: 4:00 PM EST
$13.60
$0.74(5.14%)
Day’s Range― - ―
52-Week Range$11.20 - $23.80
Previous CloseN/A
Volume1.52M
Average Volume (3M)7.84M
Market Cap
$3.60B
Enterprise Value$1.21B
Total Cash (Recent Filing)$3.99B
Total Debt (Recent Filing)$430.10M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
May 12, 2026EPS Estimate
0.97Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding229,010,000
10 Day Avg. Volume8,265,727
30 Day Avg. Volume7,843,738
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap0.34
Enterprise Value/Revenue0.10
Enterprise Value/Gross Profit0.13
Enterprise Value/Ebitda-3.10
Forecast
1Y Price Target
$16.63Price Target Upside22.28% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Margin ExpansionAnalyst expects repricing and economies of scale to drive margin expansion, supporting a path to improved profitability over time.
Market Share And EnrollmentAggressive pricing combined with a new broker bonus program has shifted members from zero-premium to paying tiers, supporting enrollment growth and market share gains.
ValuationAnalyst upgraded the stock citing an attractive valuation versus peers as margins recover in the ACA exchange market.
Bears Say
Aggressive Guidance And Underwriting RiskGuidance implies an ambitious improvement in medical loss ratio and elevated membership growth, creating doubts that underwriting and utilization trends can support the projected margins.
Policy And Subsidy ExposureAnalyst increased the probability that enhanced marketplace subsidies could expire, lowering the price target and highlighting the company’s sensitivity to policy-driven enrollment and revenue shifts.
Profitability Pressure From Medical CostsQuarterly results showed a materially higher medical loss ratio and an operating earnings shortfall, reflecting rising medical costs and utilization pressures that hurt profitability.
Oscar Health News
OSCR FAQ
What was Oscar Health’s price range in the past 12 months?
Oscar Health lowest stock price was $11.20 and its highest was $23.80 in the past 12 months.
What is Oscar Health’s market cap?
Oscar Health’s market cap is $3.60B.
When is Oscar Health’s upcoming earnings report date?
Oscar Health’s upcoming earnings report date is May 12, 2026 which is in 87 days.
How were Oscar Health’s earnings last quarter?
Oscar Health released its earnings results on Feb 10, 2026. The company reported -$1.24 earnings per share for the quarter, missing the consensus estimate of -$0.895 by -$0.345.
Is Oscar Health overvalued?
According to Wall Street analysts Oscar Health’s price is currently Undervalued.
Does Oscar Health pay dividends?
Oscar Health does not currently pay dividends.
What is Oscar Health’s EPS estimate?
Oscar Health’s EPS estimate is 0.97.
How many shares outstanding does Oscar Health have?
Oscar Health has 229,010,000 shares outstanding.
What happened to Oscar Health’s price movement after its last earnings report?
Oscar Health reported an EPS of -$1.24 in its last earnings report, missing expectations of -$0.895. Following the earnings report the stock price went up 1.738%.
Which hedge fund is a major shareholder of Oscar Health?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$16.63 (22.28% Upside)
$16.63 (22.28% Upside)
Blogger Sentiment
Bullish
OSCR Sentiment 83%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 12.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $6.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 1.0%
Last 30 Days ▼ 7.5%
Last 30 Days ▼ 7.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-13.87%
12-Months-Change
Fundamentals
Return on Equity
-44.51%
Trailing 12-Months
Asset Growth
36.86%
Trailing 12-Months
Company Description
Oscar Health
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
OSCR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a mix of significant near-term challenges and clear strategic progress. Oscar reported strong top-line growth (11.7B revenue, +28% YoY), record enrollment and major market share gains (17% → 30%), meaningful SG&A and AI-driven efficiencies, and provided bullish 2026 guidance including a return to profitability (operating earnings $250–$450M and revenue guidance up ~61% at midpoint). Offsetting these positives, 2025 was loss-making with high MLRs (87.4% full year, 95.4% in Q4), sizable risk-adjustment volatility including a $275M Q4 accrual, and uncertainty about how many passively-enrolled members will remain paid after subsidy expirations. Management articulated concrete levers to improve margins (pricing, product design, broker expansion, AI) and enacted capital actions to support growth. On balance, the call emphasized recovery and strong operational momentum for 2026 while acknowledging material risk-adjustment, enrollment and utilization uncertainties carried over from 2025.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$16.63
▲(22.28% Upside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
3.10% Insiders
20.06% Mutual Funds
3.62% Other Institutional Investors
56.71% Public Companies and Individual Investors